EUDA
EUDA Health Holdings Limited
Real Estate — Real Estate Services
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
None
1 analysts
$15.94
+$1.64 (+11.49%)
Target:
$55.00
(245.0%)
Price History
52-Week Range
Sign in to add EUDA to a watchlist or set price alerts.
Fundamentals
| Market Cap | $42.49M |
| P/E Ratio (TTM) | - |
| Forward P/E | 8.87 |
| EPS (TTM) | $-1.48 |
| Dividend Yield | - |
| Profit Margin | -40.66% |
| Revenue Growth | 78.90% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | $55.00 |
| Analysts | 1 |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 38.1 |
| Beta | 0.64 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $86.00 |
| 52-Week Low | $5.26 |
| 50-Day Avg | $14.86 |
| 200-Day Avg | $29.77 |
| Avg Volume | 117.2K |
| Volume | 3.0K |
Performance Analysis
NEUTRALEUDA presents a mixed picture with both positive and negative indicators.
~
Trading at 13% of its 52-week range.
~
RSI at 38.1 is in neutral territory.
+
Strong revenue growth of 78.9% year-over-year.
-
Operating at a loss with -40.7% margin.
~
Wall Street consensus is "none" from 1 analysts.
+
Average analyst target of $55.00 implies 245.0% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:08 UTC
Back to Screener Export Report